wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
s10637-017-0442-3
s10637-017-0442-3
https://scigraph.springernature.com/pub.10.1007/s10637-017-0442-3
Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors.
P2888
Q33439312-EA0CD77D-62B9-46AC-9E40-A700712EC780
P2888
s10637-017-0442-3
https://scigraph.springernature.com/pub.10.1007/s10637-017-0442-3